The Board of Directors of Hanall Biopharma Co.,Ltd has authorized a buyback plan on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36,950 KRW | -0.94% | +10.13% | -16.59% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.59% | 1.38B | |
+34.35% | 705B | |
+30.88% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+15.11% | 238B | |
-3.15% | 210B | |
+10.45% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- A009420 Stock
- News Hanall Biopharma Co., Ltd.
- Hanall Biopharma Co.,Ltd authorizes a Buyback Plan.